‘Diabetic patients with kidney failure need individualized care’July 30th, 2010 - 2:04 pm ICT by ANI
Washington, July 30 (ANI): Aggressive blood sugar control does not improve survival in diabetic patients with kidney failure, according to new research.
The findings, appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN), suggest that physicians should drop one-size-fits-all approach to blood sugar control and individualize blood sugar targets for patients.
Uncontrolled blood sugar levels can cause serious health problems for diabetic patients with kidney failure; however, studies provide conflicting results on the benefits and risks of aggressive blood sugar control in these individuals.
By studying 24,875 dialysis patients for a maximum of three years of follow-up, Mark Williams, MD (Joslin Diabetes Center) and his colleagues found that only sustained extremes-either high or low-in blood sugar levels increased patients’ risk of dying prematurely.
Type 2 diabetes patients with haemoglobin A1c levels (a measure of average blood sugar levels) greater 11.0 per cent were particularly at risk, with a 21 per cent increased likelihood of dying during the study. In the small (5.5 per cent) subgroup of patients with type 1 diabetes, those with hemoglobin A1c levels greater than 9 per cent had a 52 per cent increased risk of dying during the study.
“In the absence of randomized, controlled trials, these results suggest that aggressive [blood sugar] control cannot be routinely recommended for all diabetic hemodialysis patients on the basis of reducing mortality risk,” the authors concluded. They encouraged physicians who treat diabetic patients with kidney failure to individualize blood sugar targets based on the potential risks and benefits for each patient.
In reviewing the results of this study in an accompanying editorial, Joachim Ix, MD (University of California, San Diego and Veterans Affairs San Diego Healthcare System) noted that “to date, there are no data available from randomised clinical trials targeting different hemoglobin A1c levels and powered for cardiovascular events or mortality in end-stage renal disease populations. In their absence, the marked statistical power and elegant analyses provided by these… investigators provide useful insights.” He agreed that individualized haemoglobin A1c targets might be more appropriate than a one-size-fits-all target. (ANI)
- Poor response to anti-anemia drug linked to heart disease risk - Dec 29, 2010
- 2 tests better than 1 for diagnosing diabetes in overweight children - May 03, 2011
- Scientists uncover gut bug link to type 2 diabetes - Mar 14, 2012
- New guidelines urge blood test that gives blood sugar average for diagnosis - Dec 30, 2009
- Diabetes linked to irregular heartbeat - Apr 23, 2010
- Early metformin treatment doubles chance of success for diabetics - Mar 10, 2010
- Nicotine raises blood sugar among diabetic smokers: Study - Mar 28, 2011
- Cell responsible for kidney failure in diabetics found - Oct 06, 2010
- Drug used to treat type 2 diabetes linked to heart problems - Mar 18, 2011
- Can proteins in blood predict early death? - Dec 16, 2011
- Routine blood test may accurately identify pre-diabetics - Jan 07, 2011
- Benefits of intensive glucose treatment must be weighed against risks - Jun 30, 2010
- Genetic links to kidney disease, kidney failure identified - Jun 27, 2010
- Blood glucose levels indicator of retinopathy risk - Feb 15, 2011
- Depression raises risk of severe complications from diabetes - Jan 28, 2010
Tags: blood sugar control, blood sugar levels, california san diego, diabetes patients, diabetic patients, dialysis patients, healthcare system, hemodialysis patients, hemoglobin a1c levels, joslin diabetes center, kidney failure, mortality risk, patients with type, randomized controlled trials, serious health, subgroup, type 1 diabetes, type 2 diabetes, university of california san diego, veterans affairs